Personalised Health Recommendations to the General Population Through an Integrated AI Guided

Last updated: February 25, 2025
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Overall Status: Active - Recruiting

Phase

N/A

Condition

Gastric Cancer

Cancer Prevention

Cancer Treatment

Treatment

Health reccommendations

Clinical Study ID

NCT06421324
AIDA_HE
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This clinical study aims to be used to implement and validate the AIDA tool in two phases:

  • Phase 1: Risk stratification and personalised recommendations & Model development

  • Phase 2: Mechanistic Model (Bioresource) development & testing

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Subjects ≥ 18 years old with a diagnosis of GIM or previous or current H. pyloriinfection, to whom a gastroscopy is indicated within clinical care

  • Availability of a signed informed consent form to participate in the study

Exclusion

Exclusion Criteria:

  • Patients to whom an endoscopy is performed for the follow-up of another illness suchas oesophageal varices and/or for therapy such as endoscopic dilation, feeding tubeplacement or endoscopic resection

  • Subjects with a clinical diagnosis of gastric diseases other than GIM or GC

  • Patients who have received antimicrobials during the four weeks prior to theendoscopy

  • Patients who have received proton pump inhibitors and/or bismuth-based treatments atleast two weeks prior to the endoscopy

  • Subjects for whom clinical data are not available: H. pylori status, eradicationtreatment, sex, age, tobacco smoking, and first-degree family history of gastriccancer

  • Subjects who lack the mental capacity to understand the nature and requirements ofthe study and who lack the ability to give informed consent

Study Design

Total Participants: 450
Treatment Group(s): 1
Primary Treatment: Health reccommendations
Phase:
Study Start date:
June 01, 2024
Estimated Completion Date:
December 31, 2026

Study Description

The AIDA objective (project) is to develop and validate a multidisciplinary AI-powered assistant that helps clinicians diagnose precancerous inflammation, suggests personalised therapeutic strategies for medical treatment and follow-up, and makes personalised recommendations for monitoring patient health status, thus contributing to gastric cancer prevention. This prospective clinical study aims to implement and validate such tool.

Connect with a study center

  • Hospital Clínico Universitario de Valencia

    Valencia, 46010
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.